References
- Eddleston M. Patterns and problems of deliberate self‐poisoning in the developing world. Q J Med 2002; 93(11)715–731
- Eddleston M, Szinicz L, Eyer P, Buckley N. Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. Q J Med 2002; 95(5)275–283
- Sivagnanam S. Potential therapeutic agents in the management of organophosphorus poisoning. Crit Care 2002; 6(3)260–261, [PUBMED], [INFOTRIEVE], [CROSSREF]
- de Silva H J, Wijewickrema R, Senanayake N. Does pralidoxime affect outcome of management in acute organophosphorus poisoning?. Lancet 1992; 339(8802)1136–1138, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sudakin D L, Mullins M E, Horowitz B Z, Abshier V, Letzig L. Intermediate syndrome after malathion ingestion despite continuous infusion of pralidoxime. J Toxicol Clin Toxicol 2000; 38(1)47–50, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Johnson M K, Jacobsen D, Meredith T J, Eyer P, Heath A J, Ligtenstein D A, Marrs T C, Szinicz L, Vale J A, Haines J A. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emerg Med 2000; 12: 22–37
- Masson P, Froment M T, Bartels C F, Lockridge O. Importance of aspartate‐70 in organophosphate inhibition, oxime re‐activation and aging of human butyrylcholinesterase. Biochem J 1997; 325(Pt. 1)53–61, [PUBMED], [INFOTRIEVE]
- Lallement G, Baille V, Baubichon D, Carpentier P, Collombet J M, Filliat P, Foquin A, Four E, Masqueliez C, Testylier G, Tonduli L, Dorandeu F. Review of the value of huperzine as pretreatment of organophosphate poisoning. Neurotoxicology 2002; 23(1)1–5, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Clair P, Wiberg K, Granelli I, Carlsson Bratt I, Blanchet G. Stability study of a new antidote drug combination (Atropine‐HI‐6‐Prodiazepam) for treatment of organophosphate poisoning. Eur J Pharm Sci 2000; 9(3)259–263, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sungur M, Guven M. Intensive care management of organophosphate insecticide poisoning. Crit Care 2001; 5(4)211–215, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Caranto G R, Waibel K H, Asher J M, Larrison R W, Brecht K M, Schutz M B, Raveh L, Ashani Y, Wolfe A D, Maxwell D M, Doctor B P. Amplification of the effectiveness of acetylcholinesterase for detoxification of organophosphorus compounds by bis‐quaternary oximes. Biochem Pharmacol 1994; 47(2)347–357, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ashani Y, Shapira S, Levy D, Wolfe A D, Doctor B P, Raveh L. Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochem Pharmacol 1991; 41(1)37–41, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Raveh L, Grauer E, Grunwald J, Cohen E, Ashani Y. The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase. Toxicol Appl Pharmacol 1997; 145(1)43–53, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ashani Y. Prospective of human butyrilcholinesterase as a detoxifying antidote and potential regulator of controlled‐release drugs. Drug Dev Res 2000; 50: 298–308
- Epstein H M, Jarzemsky D, Zuckerman L, Vagher P. Plasma cholinesterase activity in bank blood. Anesth Analg 1980; 59(3)211–214, [PUBMED], [INFOTRIEVE]
- Ostergaard D, Viby‐Mogensen J, Hanel H K, Skovgaard L T. Half‐life of plasma cholinesterase. Acta Anaesthesiol Scand 1988; 32(3)266–269, [PUBMED], [INFOTRIEVE]
- Guven M, Sungur M, Tanrıverdi M, Eser B, Kekec Z. Evaluation of the patients with acute intoxication. Turk J Med Sci 2002; 32: 169–172
- Khan S, Hemalatha R, Jeyaseelan L, Oommen A, Zachariah A. Neuroparalysis and oxime efficacy in organophosphate poisoning: a study of butyrylcholinesterase. Hum Exp Toxicol 2001; 20(4)169–174, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- De Bleecker J L. The intermediate syndrome in organophosphate poisoning: an overview of experimental and clinical observations. J Toxicol Clin Toxicol 1995; 33(6)683–686, [PUBMED], [INFOTRIEVE], [CSA]
- Senanayake N, Karalliedde L. Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome. N Engl J Med 1987; 316(13)761–763, [PUBMED], [INFOTRIEVE]
- Karalliedde L. Organophosphorus poisoning and anaesthesia. Anaesthesia 1999; 54: 1073–1088, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Johnson S, Peter J V, Thomas K, Jeyaseelan L, Cherian A M. Evaluation of two treatment regimens of pralidoxime (1 gm single bolus dose vs. 12 gm infusion) in the management of organophosphorus poisoning. J Assoc Phys India 1996; 44(8)529–531, [CSA]
- Cherian A M, Peter J V, Samuel J, Jaydevan R, Peter S, Joel S, Jeyaseelan L, Thomas K. Effectivenes of 2PAM (PAM‐Pralidoxime) in the treatment of organophosphorus poisoning: a randomized double‐blind, placebo‐controlled clinical trial. J Assoc Phys India 1997; 45: 22–24
- Kwong T C. Organophosphate pesticides: biochemistry and clinical toxicology. Ther Drug Monit 2002; 24: 144–149, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kassa J. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 2002; 40: 803–816, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Aygun D, Doganay Z, Altintop L, Guven H, Onar M, Deniz T, Sunter T. Serum acetylcholinesterase and prognosis of acute organophosphate poisoning. J Toxicol Clin Toxicol 2002; 40: 903–910, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Guven M, Dogukan A, Taskapan H, Çetin M. Leucocytosis as a parameter in management of organophosphate intoxication. Turk J Med Sci 2000; 30: 499–500, [CSA]
- Raveh L, Grunwald J, Marcus D, Papier Y, Cohen E, Ashani Y. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity: in vitro and in vivo quantitative characterization. Biochem Pharmacol 1993; 45: 2465–2474, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Broomfield C A, Maxwell D M, Solana R P, Castro C A, Finger A V, Lenz D E. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. J Pharmacol Exp Ther 1991; 259: 633–638, [PUBMED], [INFOTRIEVE], [CSA]
- Grunwald J, Marcus D, Papier Y, Raveh L, Pittel Z, Ashani Y. Large‐scale purification and long‐term stability of human butyrylcholinesterase: a potential bioscavenger drug. J Biochem Biophys Methods 1997; 34: 123–135, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Li B, Stribley J A, Ticu A, Xie W, Schopfer L M, Hammond P, Brimijoin S, Hinrichs S H, Lockridge O. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J Neurochem 2000; 75: 1320–1331, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sams C, Mason H J. Detoxification of organophosphates by A‐esterases in human serum. Hum Exp Toxicol 1999; 18(11)653–658, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dettbarn W D, Yang Z P, Milatovic D. Different role of carboxylesterases in toxicity and tolerance to paraoxon and DFP. Chem Biol Interact 1999; 120: 445–454, [CROSSREF]
- Jenkins T, Balinsky D, Patient D W. Cholinesterase in plasma: first reported absence in the Bantu half‐life determination. Science 1967; 156: 1748–1750, [PUBMED], [INFOTRIEVE]
- Garry P J, Prince L C, Notari R E. Half‐life human serum cholinesterase following blood transfusion. Res Commun Chem Pathol Pharmacol 1974; 8: 371–380, [PUBMED], [INFOTRIEVE]
- Smith D C, Ridley S A, Donaldson K F. Fresh frozen plasma and edrophonium in a patient with a plasma cholinesterase deficiency. Anaesthesia 1993; 48: 511–513, [PUBMED], [INFOTRIEVE]
- Zhong P, Wang Q, Sheng H. Alteration of banked blood cholinesterase level and its significance in emergency treatment of acute organophosphorus pesticide poisoning. Zhonghua Nei Ke Za Zhi 2000; 39(10)658–659, [PUBMED], [INFOTRIEVE], [CSA]